Navigation Links
Researchers unveil new assessment for diagnosing malnutrition

A new systematic assessment of malnutrition, created by researchers at Penn State, will aid dietitians and other health care providers in diagnosis and treatment.

Up to 50 percent of patients in hospitals and nursing facilities are estimated to be malnourished, according to Gordon Jensen, professor and head of nutritional sciences, Penn State. Although malnutrition is widespread, confusion exists in the clinical community on how to best make this diagnose. Malnourished patients are frequently not identified as such, and those not affected are sometimes thought to be malnourished.

"Our systematic assessment is a new approach created for health care professionals to enable them to appropriately diagnosis and treat malnutrition in patients," said Jensen.

Supported by the Academy of Nutrition and Dietetics and the American Society for Parenteral and Enteral Nutrition, the new approach to diagnosis describes syndromes of malnutrition in the context of starvation, chronic disease and/or acute disease or injury.

"While it may be obvious that a person suffering from starvation -- as a result of an eating disorder or depression, for example -- is malnourished, it may be less obvious that a person suffering from a chronic disease, such as diabetes or rheumatoid arthritis, or from an acute disease or injury, such as major trauma from an auto accident or a serious blood-borne infection, is malnourished," said Jensen.

According to Jensen, patients with chronic or acute disease or injury may suffer from malnutrition as a result of their bodies' natural and sometimes exaggerated inflammatory responses to disease or injury, which can trigger a loss of appetite, abnormal metabolism and muscle breakdown.

"Inflammation is an important underlying factor that increases risk for malnutrition," he said. "Those patients with chronic disease tend to have inflammation that is chronic and of mild to moderate degree, while those with acute disease or injury tend to have inflammation that is acute and of severe degree."

That is why, in addition to providing health care workers with instructions for determining if a patient is suffering from malnutrition in the context of starvation, chronic disease and/or acute disease or injury, the assessment also suggests that health care workers evaluate patients' inflammatory status. This new approach can help guide practitioners in discerning appropriate nutrition interventions and anticipated outcomes.

The assessment appears in the May issue of the Journal of Parenteral and Enteral Nutrition. A companion paper that more thoroughly describes the necessity for the new assessment is in the May issues of both the Journal of Parenteral and Enteral Nutrition and the Journal of the Academy of Nutrition and Dietetics.

"The new assessment is part of a national effort to educate and implement the use of a more systematic and thorough approach to diagnosing malnutrition," said Jensen. "Our hope is that it will help ensure high-quality, cost-effective care for people suffering from malnutrition."

The researchers look forward to testing the effectiveness of the new approach to assessment and diagnosis in health care systems throughout the United States.

Contact: Sara LaJeunesse
Penn State

Related biology news :

1. Researchers show prebiotic can reduce severity of colitis
2. Game on! UCLA researchers use online crowd-sourcing to diagnose malaria
3. Americas clean energy policies need a reality check, say Stanford researchers
4. Researchers find potential dark side to diets high in beta-carotene
5. Researchers at Hebrew University identify genetic systems disrupted in autistic brain
6. Light weights are just as good for building muscle, getting stronger, researchers find
7. Researchers develop rapid test strips for bacterial contamination in swimming water
8. Researchers question pulling plug on pacifiers
9. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
10. Researchers announce GenomeSpace environment to connect genomic tools
11. Evidence shows that anti-depressants likely do more harm than good, researchers find
Post Your Comments:
(Date:9/24/2015)... 24, 2015  EyeLock LLC, a market leader of ... winning and latest technology in Booth #602 at next ... . EyeLock,s iris authentication technology provides an ... accuracy, making it the most proven way to authenticate ... technology to deliver a fast and friendly user experience ...
(Date:9/10/2015)... 2015 Report Details Emerging ... Opportunities and Revenue Prospects to Help You Stay ... especially new drug classes? Get the latest technological ... exclusive market data and industry knowledge, benefitting your ... opportunities and sales predictions. Visiongain,s new study ...
(Date:9/10/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that the ... Modern, will feature the Wocket® smart wallet for the ... Touch Of Modern is an online ... to its 7.2 million members. Customers are affluent, urban ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... 2015 Research and Markets( ) has ... Markets for Bone Morphogenetic Protein Growth Factor Therapy - ... --> --> Bone morphogenetic ... of bone after a fracture. In nature, these proteins ... formation of the skeleton. There are twenty different BMPs ...
(Date:10/13/2015)... SAN DIEGO , Oct. 13, 2015 /PRNewswire/ ... agreed to collaborate in the development of a higher ... by BASF under the Kolliphor ® P188 brand, ... and biological applications, such as a shear protectant in ... for Mast,s lead product candidate. Under the agreement between ...
(Date:10/13/2015)... ... October 13, 2015 , ... Exotic ... material handling solutions and components, is opening its latest Parker Store retail location ... facility is Exotic’s second major expansion in Metropolitan Detroit in less than a ...
(Date:10/13/2015)... , October 13, 2015 the United ... Europe .  PRCC represents about 14% of all new cases ... , Canada and Europe ... kidney cancer.   --> Hutchison China MediTech Limited ("Chi-Med") ... R&D subsidiary, and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in ...
Breaking Biology Technology: